Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
3(20%)
Results Posted
9%(1 trials)

Phase Distribution

Ph phase_2
1
7%
Ph phase_1
11
73%
Ph phase_3
3
20%

Phase Distribution

11

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
11(73.3%)
Phase 2Efficacy & side effects
1(6.7%)
Phase 3Large-scale testing
3(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

15

all time

Status Distribution
Active(4)
Completed(11)

Detailed Status

Completed11
Active, not recruiting2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 111 (73.3%)
Phase 21 (6.7%)
Phase 33 (20.0%)

Trials by Status

completed1173%
recruiting17%
active_not_recruiting213%
not_yet_recruiting17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT06025578Phase 3

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

Active Not Recruiting
NCT06003426Phase 3

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Active Not Recruiting
NCT07422298Phase 1

A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants

Recruiting
NCT07441408Phase 3

Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

Not Yet Recruiting
NCT04308681Phase 2

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Completed
NCT06723535Phase 1

A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis

Completed
NCT06746402Phase 1

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986278 on Cardiac Repolarization in Healthy Participants

Completed
NCT06425198Phase 1

Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Completed
NCT05985590Phase 1

A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants

Completed
NCT05932303Phase 1

A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

Completed
NCT05805904Phase 1

A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986278 in Healthy Chinese Participants

Completed
NCT05684289Phase 1

A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

Completed
NCT03981094Phase 1

A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants

Completed
NCT03429933Phase 1

A Study of Experimental Medication BMS-986278 Given to Healthy Participants

Completed
NCT03712540Phase 1

An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15